Progesterone levels in cesarean and normal delivered term placentas

Archives of Gynecology and Obstetrics

Volumn 281, Issue 3, 2010, Pages 387-392

  Feinshtein, Valeria ^a   Ben Zvi, Zvi ^a   Sheiner, Eyal ^b   Amash, Alaa ^a   Sheizaf, Boaz ^b   Holcberg, Gershon ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cesarean section; Delivery; Lacenta; Progesterone

Indexed keywords

PROGESTERONE;

ARTICLE; BIRTH; CESAREAN SECTION; CHEMOLUMINESCENCE; CONTROLLED STUDY; COTYLEDON; EX VIVO STUDY; FEMALE; GESTATION PERIOD; HUMAN; HUMAN TISSUE; LABOR ONSET; PLACENTA PERFUSION; PLACENTAL DELIVERY; PREGNANCY; PROGESTERONE RELEASE; PROGESTERONE SYNTHESIS; SYNCYTIOTROPHOBLAST; VAGINAL DELIVERY;

CESAREAN SECTION; DELIVERY, OBSTETRIC; FEMALE; HUMANS; IMMUNOCHEMISTRY; LABOR, OBSTETRIC; PLACENTA; PREGNANCY; PROGESTERONE;

EID: 77950627677     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-1125-x     Document Type: Article

References (27)

1. Weier N, He SM, Li XT, Wang LL, Zhou SF. (2008) Placental drug disposition and its clinical implications. Curr Drug Metab 9:106-121. doi:10.2174/138920008783571828 (Pubitemid 351461000)
2. Skałba P, Dabkowska-Huć A, Chełmicki Z. (2003) The endocrinology of the human placenta. Wiad Lek 56:475-480
3. SperoV L, Fritz MA. (2005) Clinical gynecologic endocrinology and infertility, 7th edn. Lippincott Williams & Wilkins, Philadelphia 4. Denschlag D, Keck C. (2002) The corpus luteum. Ther Umsch 59:159-162. doi:10.1024/0040-5930.59.4.159
4. Grow DR. (2002) Metabolism of endogenous and exogenous reproductive hormones. Obstet Gynecol Clin North Am 29:425-436. doi:10.1016/S0889-8545(02) 00009-8
5. Critchley HOD, Kelly RW, Brenner RM, Baird DT. (2003) Antiprogestins as a model for progesterone withdrawal. Steroids 68:1061-1068. doi:10.1016/j. steroids.2003.07.001 (Pubitemid 37532431)
6. Arck P, Hansen PJ, Mulac Jericevic B, Piccinni MP, Szekeres-Bartho J. (2007) Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. Am J Reprod Immunol 58:268-279. doi:10.1111/j.1600-0897.2007.00512.x (Pubitemid 47249065)
7. Tuckey RC. (2005) Progesterone synthesis by the human placenta. Placenta 26:273-281. doi:10.1016/j.placenta.2004.06.012 (Pubitemid 40485864)
8. Miyaura H, Iwata M. (2002) Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 168:1087-1094 (Pubitemid 34094472)
9. Shanker YG, Shetty UP, Rao AJ. (1998) Regulation of low density lipoprotein receptor mRNA levels by estradiol 17beta and chorionic gonadotropin in human placenta. Mol Cell Biochem 187:133-139. doi:10.1023/A:1006843812495 (Pubitemid 28454283)
10. Pasqualini JR. (2005) Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol 97:401-415. doi:10.1016/j.jsbmb.2005.08.004 (Pubitemid 41691878)
11. Bernal AL. (2001) Overview of current research in parturition. Exp Physiol 86:213-222. doi:10.1113/eph8602178 (Pubitemid 32266456)
12. Smith R. (2007) Parturition. N Engl J Med 356:271-283. doi:10.1056/NEJMra061360 (Pubitemid 46143230)
13. Mesiano S. (2004) Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 11:193-202. doi:10.1016/j.jsgi. 2003.12.004 (Pubitemid 38561362)
14. Thijssen JH. (2005) Progesterone receptors in the human uterus and their possible role in parturition. J Steroid Biochem Mol Biol 97:397-400. doi:10.1016/j.jsbmb.2005.08.011 (Pubitemid 41691877)
15. Mesiano S. (2007) Myometrial progesterone responsiveness. Semin Reprod Med 25:5-13. doi:10.1055/s-2006-956771 (Pubitemid 46147840)
16. Zakar T, Hertelendy F. (2007) Progesterone withdrawal: key to parturition. Am J Obstet Gynecol 196:289-296. doi:10.1016/j.ajog.2006.09.005 (Pubitemid 46509609)
17. Sheehan PM, Rice GE, Moses EK, Brennecke SP. (2005) 5 Betadihydroprogesterone and steroid 5 beta-reductase decrease in association with human parturition at term. Mol Hum Reprod 11:495-501. doi:10.1093/molehr/ gah201 (Pubitemid 41258236)
18. Schneider H, Huch A. (1985) Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentation. Contrib Gynecol Obstet 13:40-47 (Pubitemid 15120212)
19. Myren M, Mose T, Mathiesen L, Knudsen LE. (2007) The human placenta-an alternative for studying foetal exposure. Toxicol In Vitro 21:1332-1340. doi:10.1016/j.tiv.2007.05.011 (Pubitemid 350026248)
20. Holcberg G, Sapir O, Tsadkin M, Huleihel M, Lazer S, Katz M, Mazor M, Ben-Zvi Z. (2003) Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil in human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 109:133-137. doi:10.1016/S0301-2115(02)00513-4 (Pubitemid 36809119)
21. Kopecky EA, Simone C, Knie B, Koren G. (1999) Transfer of morphine across the human placenta and its interaction with naloxone. Life Sci 65:2359-2377. doi:10.1016/S0024-3205(99)00503-2 (Pubitemid 29531039)
22. Shargel L, Cheung WM, Yu AB. (1979) High-pressure liquid chromatographic analysis of antipyrine in small plasma samples. J Pharm Sci 68:1052-1054. doi:10.1002/jps.2600680835 (Pubitemid 9242719)
23. Löfgren M, Bäckström T. (1997) High progesterone is related to effective human labor. Study of serum progesterone and 5 alphapregnane-3, 20-dione in normal and abnormal deliveries. Acta Obstet Gynecol Scand 76:423-430. doi:10.3109/00016349709047823 (Pubitemid 27226263)
24. Maynard PV, Stein PE, Symonds EM. (1980) Umbilical cord plasma progesterone at term in relation to mode of delivery. Br J Obstet Gynaecol 87:864-868 (Pubitemid 11225811)
25. Aisien AO, Towobola OA, Otubu JA, Imade GE. (1994) Umbilical cord venous progesterone at term delivery in relation to mode of delivery. Int J Gynaecol Obstet 47:27-31. doi:10.1016/0020-7292(94)90457-X (Pubitemid 24292421)
26. Mesiano S, Chan EC, Fitter JT, Kwek K, Yeo G, Smith R. (2002) Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 87:2924-2930. doi:10.1210/jc.87.6.2924 (Pubitemid 34655365)
27. Fortson J, Howe L, Harmon C, Sherrill WW. (2008) Targeting cardiovascular risk: early identiWcation of insulin resistance. J Am Acad Nurse Pract 20:319-325. doi:10.1111/j.1745-7599.2008. 00324.x